Goerz G, Krieg T
Dtsch Med Wochenschr. 1978 Aug 25;103(34):1329-33. doi: 10.1055/s-0028-1129257.
In 4 of 12 patients with porphyria cutanea tarda (PCT) treatment with p-aminobenzoic acid (PABA) achieved normal porphyrin excretion and disappearance of the skin changes. But this result is far worse than that obtained with the venesection method of Ippen. PABA treatment should, therefore, be discontinued.--Among 56 patients (37 males, 19 females) given chloroquine treatment (twice 125 mg per week), normal porphyrin excretion and disappearance of the skin changes occurred in 32 after an average duration of treatment of 8 months, while in 21 (15 males and 6 females) an improvement set in after an average treatment duration of only 5 months so far. The treatment failed in three patients, but one of them lapsed his treatment and one died of an intercurrent disease, so that only one can be reckoned a true failure of chloroquine treatment.
在12例迟发性皮肤卟啉病(PCT)患者中,有4例接受对氨基苯甲酸(PABA)治疗后卟啉排泄恢复正常,皮肤病变消失。但这一结果远不如伊彭采用放血疗法所取得的效果。因此,应停止使用PABA治疗。——在56例接受氯喹治疗(每周两次,每次125毫克)的患者(37例男性,19例女性)中,32例在平均治疗8个月后卟啉排泄恢复正常,皮肤病变消失,而21例(15例男性和6例女性)到目前为止在平均仅治疗5个月后病情有所改善。3例患者治疗失败,但其中1例中断治疗,1例死于并发疾病,所以只能认为1例是氯喹治疗真正失败。